Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the reported withdrawal of the original formulation of Questran from the UK market on patients with bile acid malabsorption.

I refer the Hon Member to the answer he was provided on 8 June in response to Questions 4511 and 4512. If there are any new developments to report in this area, I will ensure that he is updated.